Business
Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering
ZUG, Switzerland, March 11, 2026--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering ("ABO") of Galderma shares by Sunshine SwissCo GmbH ("EQT"), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the "Selling Shareholders") launch
About this update from Galderma Group Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":823,"height":209,"url":"https://media.zenfs.com/en/business-wire.com/5746d959d0be8b8e55c66fe670494ad1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fdBwLfed8atYt3Y4JDnx2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5746d959d0be8b8e55c66fe670494ad1","width":823,"height":209},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/JqoNnAZLSBav5WZXcFoFrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2NDY7aD00MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/5746d959d0be8b8e55c66fe670494ad1","width":823,"height":209}},"lazy":false},{"type":"text","content":"Ad hoc announcement pursuant to Art. 53 LR","length":42,"tagName":"p"},{"type":"text","content":"ZUG, Switzerland, March 11, 2026--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering ("ABO") of Galderma shares by Sunshine SwissCo GmbH ("EQT"), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the "Selling Shareholders") launched yesterday evening. The repurchase was made at the same price per share determined by the bookbuilding offering.","length":661,"tagName":"p"},{"type":"text","content":"As a result of yesterday evening’s ABO, the Selling Shareholders have fully divested their remaining stake in Galderma.","length":119,"tagName":"p"},{"type":"text","content":"The repurchase, which is expected to settle on March 13 is being financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to deliver on its strategic and financing priorities.","length":210,"tagName":"p"},{"type":"text","content":"The shares will be held in treasury for future use in connection with Galderma's employee participation plans, business development opportunities and/or treasury management.","length":177,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;background-color:#CCEEFF;padding-left:0.0px;","val":[{"type...